
Terumo Corporation – OTC:TRUMY
Terumo stock price today
Terumo stock price monthly change
Terumo stock price quarterly change
Terumo stock price yearly change
Terumo key metrics
Market Cap | 21.38B |
Enterprise value | 4.09T |
P/E | 38.24 |
EV/Sales | 4.44 |
EV/EBITDA | 18.99 |
Price/Sales | 4.41 |
Price/Book | 3.06 |
PEG ratio | 0.02 |
EPS | 82.02 |
Revenue | 799.79B |
EBITDA | 174.98B |
Income | 84.44B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 11.54% |
Oper. margin | 14.77% |
Gross margin | 51.98% |
EBIT margin | 14.77% |
EBITDA margin | 21.88% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTerumo stock price history
Terumo stock forecast
Terumo financial statements
Dec 2021 | 178.84B | 21.70B | 12.14% |
---|---|---|---|
Mar 2022 | 179.82B | 17.11B | 9.52% |
Mar 2023 | 202.21B | 19.14B | 9.47% |
Mar 2024 | 238.91B | 26.47B | 11.08% |
Sep 2025 | 250.57B | 36.76B | 14.67% |
---|---|---|---|
Oct 2025 | 261.23B | 36.76B | 14.07% |
Dec 2025 | 260.82B | 39.76B | 15.24% |
Mar 2026 | 258.31B | 40.57B | 15.71% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 30.09% |
---|
2020 | 0.73% |
---|---|
2021 | 0.7% |
2022 | 0.84% |
2023 | 1.04% |
2024 | 0.8% |
Sep 2022 | 1658931000000 | 487.82B | 29.41% |
---|---|---|---|
Dec 2022 | 1543470000000 | 469.75B | 30.44% |
Mar 2023 | 1602225000000 | 491.16B | 30.65% |
Mar 2024 | 1831402000000 | 504.30B | 27.54% |
Dec 2021 | 31.62B | -18.76B | -14.11B |
---|---|---|---|
Mar 2022 | 43.11B | -19.20B | -31.61B |
Mar 2023 | 42.67B | -17.21B | -2.10B |
Mar 2024 | 55.13B | -28.40B | 6.63B |
Terumo alternative data
Aug 2023 | 30,207 |
---|---|
Sep 2023 | 30,207 |
Oct 2023 | 30,207 |
Nov 2023 | 30,207 |
Dec 2023 | 30,207 |
Jan 2024 | 30,207 |
Feb 2024 | 30,207 |
Mar 2024 | 30,207 |
Apr 2024 | 30,207 |
May 2024 | 30,207 |
Jun 2024 | 30,207 |
Jul 2024 | 30,207 |
Terumo other data
Quarter | Transcript |
---|---|
Q4 2024 16 May 2024 | Q4 2024 Earnings Call Transcript |
Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment
Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025
Haemonetics Executing Well, But Valuation Dogged By Concerns About A Large Customer
Diabetes Deep-Dive With DexCom And Embecta: Polar Opposite Diabetes Plays
-
What's the price of Terumo stock today?
One share of Terumo stock can currently be purchased for approximately $18.79.
-
When is Terumo's next earnings date?
Unfortunately, Terumo's (TRUMY) next earnings date is currently unknown.
-
Does Terumo pay dividends?
Yes, Terumo pays dividends and its trailing 12-month yield is 0.01% with 30% payout ratio. The last Terumo stock dividend of undefined was paid on 6 Sep 2025.
-
How much money does Terumo make?
Terumo has a market capitalization of 21.38B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.39% to 921.86B US dollars.
-
What is Terumo's stock symbol?
Terumo Corporation is traded on the OTC under the ticker symbol "TRUMY".
-
What is Terumo's primary industry?
Company operates in the Healthcare sector and Medical Instruments & Supplies industry.
-
How do i buy shares of Terumo?
Shares of Terumo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Terumo have?
As Jul 2024, Terumo employs 30,207 workers.
-
When Terumo went public?
Terumo Corporation is publicly traded company for more then 15 years since IPO on 5 Jan 2010.
-
What is Terumo's official website?
The official website for Terumo is terumo.co.jp.
-
How can i contact Terumo?
Terumo can be reached via phone at +81 3 3374 8111.
Terumo company profile:

Terumo Corporation
terumo.co.jpOTC
28,294
Medical Instruments & Supplies
Healthcare
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
Tokyo, 151-0072
:
ISIN: US88156J1051
CUSIP: 88156J105